Beyond Hair Loss: Can a Common Baldness Pill Protect Your Heart?

Spread the Message

Read Time:4 Minute, 57 Second

Published: March 16, 2026

URBANA, Ill. — A decades-old medication primarily used to treat male pattern baldness and enlarged prostates may have a surprising second act as a cardiovascular protector. Recent research from the University of Illinois suggests that finasteride, known by the brand names Propecia and Proscar, could significantly lower cholesterol levels and slow the progression of atherosclerosis (hardening of the arteries). The study, which combined high-dose animal trials with an analysis of federal health data, offers a provocative look at how hormone-modulating drugs might be repurposed to combat the world’s leading cause of death: heart disease.

A New Frontier for a 30-Year-Old Drug

Finasteride has been a staple in men’s health since its FDA approval in 1992. It works by inhibiting the enzyme 5-alpha-reductase, which prevents the conversion of testosterone into dihydrotestosterone (DHT). While DHT is essential for male development, in adulthood it is the primary culprit behind hair follicle miniaturization and the growth of the prostate gland.

However, researchers led by Dr. Jaume Amengual, an assistant professor at the University of Illinois, suspected that DHT might also play a clandestine role in how the body manages fats. Their findings, recently published in the Journal of Lipid Research, indicate that by suppressing DHT, finasteride may inadvertently improve the body’s lipid profile.

From the Lab to National Surveys

The research team employed a dual-track approach to validate their hypothesis, looking at both controlled laboratory environments and real-world human data.

1. The Animal Model

To test the drug’s impact on physical arterial health, researchers used mice genetically modified to be deficient in LDL receptors, making them highly susceptible to high cholesterol and atherosclerosis. The mice were fed a “Western diet” (high-fat, high-cholesterol) and administered varying doses of finasteride.

The results were striking. Mice given the highest doses showed:

Reduced Plasma Cholesterol: Significant drops in circulating fats.
Plaque Reduction: A visible decrease in the buildup of arterial plaque.
Liver Health: Fewer inflammatory markers and lipids in the liver, suggesting the organ was “burning” more fat rather than storing it.

“Mice that were given a high dose of finasteride showed lower cholesterol levels within the plasma as well as in the arteries,” noted Donald Molina Chaves, a doctoral student involved in the study.

2. The Human Connection

The researchers then turned to the National Health and Nutrition Examination Survey (NHANES) data from 2009 to 2016. Among the thousands of participants, they identified a subset of men taking finasteride.

The observational data mirrored the lab results: men using finasteride for hair loss had total cholesterol levels approximately 30 points lower than non-users. This correlation remained significant even after adjusting for age and other health factors.

Expert Perspectives: Cautious Optimism

While the results are compelling, the medical community is treating the news with measured enthusiasm.

Dr. Rigved Tadwalkar, a consultative cardiologist at Providence Saint John’s Health Center, described the findings as a “potential new avenue for research.” He noted that while the study provides “reasonable evidence” for cardiovascular benefits, it is not yet enough to change clinical guidelines.

Similarly, Dr. Nikki Bart, a heart failure cardiologist at St Vincent’s Hospital Sydney, emphasized the “gold standard” requirement for medical change. “To understand whether finasteride is truly beneficial for the heart, a randomized control trial (RCT) comparing finasteride against a placebo in humans would need to be performed,” she explained.

Implications for Public Health

The potential for “repurposing” finasteride is particularly interesting because the drug is already off-patent and relatively inexpensive.

Potential High-Risk Beneficiaries

Men with BPH: Patients already taking the 5 mg dose for prostate issues might be receiving “stealth” heart benefits.
Transgender Individuals: Dr. Amengual noted that for transgender women on hormone therapy—who may face elevated cardiovascular risks due to hormonal shifts—finasteride could offer a dual benefit of managing hair loss while protecting the heart.
Early Intervention: Dr. Samantha Lee of Staten Island University Hospital noted that cardiology is shifting toward earlier prevention. Having another tool in the “toolbox” to prevent plaque buildup before it becomes life-threatening is a significant development.

Understanding the Risks: Not a “Magic Pill”

Despite the promising heart data, finasteride is not without controversy. The drug is associated with several side effects that patients must weigh carefully:

Sexual Dysfunction: Reported in roughly 1.3% to 15.8% of users, including erectile dysfunction and loss of libido.
Post-Finasteride Syndrome (PFS): A rare but serious cluster of persistent symptoms—including depression, anxiety, and cognitive “fog”—that some patients report even after stopping the medication.
Dosage Discrepancy: The doses used in the mouse study were significantly higher than the 1 mg or 5 mg doses typically prescribed to humans. It remains unclear if the lower “hair loss dose” provides the same level of heart protection seen in the lab.

Furthermore, Dr. Bart warned that finasteride can interact with certain medications for pulmonary hypertension and nitrates, making it unsuitable for some existing heart patients.

The Bottom Line for Consumers

For now, the University of Illinois study serves as a “hypothesis-generating” discovery. It suggests that our hormones and our heart health are more deeply intertwined than previously thought.

If you are currently taking finasteride for hair loss or an enlarged prostate, these findings are an encouraging “side effect.” However, experts strongly advise against starting the medication solely for heart health until human clinical trials are completed. For the general public, the pillars of heart health remain unchanged: a balanced diet, regular exercise, and tobacco cessation.

Medical Disclaimer

This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.